MY Health Care Blog

  Downstream processing is used to manufacture antibiotics, antibodies, hormones, vaccines and also used for the production of industrial enzymes. In downstream processing, the purification and recovery of biosynthetic products is done that are derived from natural sources such as tissues of animals and plants. The  downstream processing market growth  is fuelled by the ever growing demand for biopharmaceuticals and increasing R&D spending on the development of such products. However, the high cost of the instruments involved in downstream processing and a dearth of skilled workforce is hampering the growth of this market. The global downstream processing market is slated to touch a value of about US$ 25,800 Mn in the year 2022 and display a robust CAGR during the assessment period. Forecast Highlights on Global Downstream Processing Market As per the forecast of Future Market Insights, the filters product type segment is slated to touch a value of nearly US...

  Future Market Insights recently conducted its forecast study on the global market for  varicose vein treatments , estimating the market’s current value at just over US$ 500 Mn. The report, titled “Varicose Vein Treatment Market: Global Industry Analysis and Opportunity Assessment, 2016-2026,” projects that rising prevalence of obesity will fuel the incidence rate of varicose veins in the world. Occurrence of varicose vein is medically-proven to be higher among obese people. Along with this, the demand for varicose vein treatments is also expected to grow on the account of effectiveness of the treatments, utilisation of user-friendly devices, and growing emphasis of medical practitioners on ensuring patient safety during critical treatment of varicose veins. Towards the end of 2026, the global market for varicose vein treatment will have reached value of US$ 931.4 Mn, registering a robust growth at 6.4% CAGR. Unattended varicose veins can cause one severe pain through swellin...

  Future Market Insights, in its latest research, delivers key insights on the factors impacting the global  digital mobile X-ray device market growth . According to the report, demand for digital mobile X-ray devices will continue to be fuelled by applications in orthopaedic- and chest-imaging. These two end-use applications accounted for 60% revenue share of the market in 2016. Key Driving Factors Increasing emphasis on diagnostic imaging services by various government bodies. Increasing geriatric population – according to WHO, global geriatric population will reach 2 billion by 2050 Rising incidences of orthopaedic diseases and bone injuries – WHO estimates global prevalence of arthritis to between 0.3% and 1% Contractual agreements and acquisitions by manufacturers Increasing adoption of 3D medical imaging equipment, especially in the field of orthopaedics Increase in the number of free standing imaging centers Key Restraints High cost of clinical trials and stringent regu...

 The research report titled “ Orthobiologics Market Demand : Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” covers annual sales revenue generated by various market segments during the period of assessment 2017-2027. Furthermore, developments taking place in the market, various trends impacting the performance of the market and other drivers fuelling revenue growth of the global orthobiologics market are enumerated in this elaborate research study. Certain challenges that are pulling market growth southward are also assessed in this report. The report presents a high-level overview of the global orthobiologics market to the reader and extends support in planning future moves by portraying an accurate forecast model of the global orthobiologics market. Global Orthobiologics Market: Key Forecast Highlights The global orthobiologics market research report features the current market scenario as well as the future growth prospects. Accor...

  Future Market Insights (FMI) delivers key insights on the global  spinal fusion market size  in its upcoming report titled “Spinal Fusion Market: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017 – 2027.” In terms of revenue, the global spinal fusion market is projected to register a CAGR of 5.4% over the forecast period, owing to various factors, regarding which FMI offers detailed insights and forecasts in this report. A key trend witnessed in the global spinal fusion market is the rise in the development of minimising load due to increasing adverse reactions. Furthermore, the growing importance of developing advanced products among big players to enhance their product portfolio is another key trend in the global spinal fusion market. Major factors that contribute toward growth of the  spinal fusion devices  market include the shift toward minimally invasive spin procedures, increase in the prevalence of spinal disorders, and advan...

The global  prosthetic heart valve market share   is estimated to register a strong  CAGR of 12.0%  over the forecast period and exceed a market valuation of  US$ 19.60 Billion  by the end of 2026. According to Future Market Insights, an increasing prevalence of valvular heart disease (VHD) is expected to augment growth of the global prosthetic heart valve market during the forecast period. Regulatory approval for heart valves, integration of technological advancements, and increasing number of heart valve implantation procedures are other factors expected to influence revenue growth of the global prosthetic heart valve market in the next 10 years. However, high costs associated with transcatheter heart valve products, procedure related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period. Prosthetic Heart Valve Market Key Segmentation : By Product T...

  Peptide therapeutics are witnessing substantial demand, owing to increasing application in the treatment of various chronic disease such as cancer, cardiovascular diseases, hematologic diseases, and gastro-intestinal diseases. Rising prevalence of these chronic diseases across the world is further expected to widen the existing patient pool. Therapeutic efficacy of  peptide therapeutics  is relatively superior as compared to other marketed drugs, resulting in their higher adoption among physicians. The global peptide therapeutics market was valued at US$ 25.6 Bn in 2021, and is expected to exhibit a healthy CAGR of 11% during the forecast period (2022-2025). The COVID-19 pandemic has been severely affecting the global economic order, and, in turn, the peptide therapeutics market. Restrictions on traveling, self-quarantines, and social distancing regulations, on a national scale, are resulting in notable drop in business and consumer spending through Q2. Key Takeaways of...